Señales en vivo de ADVM | Maximiza tus Ganancias con Getagraph.com

COMPRAR 114600 min ago

@ $2.19

Emitido: 14 feb 2024 @ 09:34

Retorno: 376.26%

Señal anterior: feb 12 - 16:00

Señal anterior: Vender

Retorno: 10.05 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	899 803
Volumen promedio	330 547
Capitalización de mercado	216.47M
EPS	$0 ( 2024-04-04 )
Próxima fecha de ganancias	( $-1.280 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.900
ATR14	$0.0190 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Seyedkazemi Setareh	Buy	85 000	Stock Option (Right to Buy)
2023-10-03	Soparkar Peter	Buy	130 000	Stock Option (Right to Buy)
2023-10-03	Fischer Laurent	Buy	315 000	Stock Option (Right to Buy)
2024-02-12	Seyedkazemi Setareh	Buy	400 000	Stock Option (Right to Buy)
2024-02-12	Fischer Laurent	Buy	1 104 200	Stock Option (Right to Buy)

INSIDER POWER
97.20
Last 100 transactions
Buy: 14 665 896 \| Sell: 1 551 540

Volumen Correlación

Largo: 0.03 (neutral)

Corto: -0.48 (neutral)

Signal:(31.498) Neutral

Adverum Biotechnologies Correlación

10 Correlaciones Más Positivas
RVNC	0.965
VCNX	0.964
LYT	0.963
SBET	0.959
RSLS	0.957
HA	0.957
BCLI	0.956
FDMT	0.955
STKS	0.954
TNYA	0.953

10 Correlaciones Más Negativas
RMRM	-0.971
ACQR	-0.963
TBSA	-0.962
HERA	-0.962
NVSA	-0.961
FRSG	-0.961
LEGA	-0.96
FTPA	-0.96
GXII	-0.96
AGGR	-0.96

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adverum Biotechnologies Correlación - Moneda/Commodity

-0.61
( weak negative )

-0.64
( weak negative )

0.00
( neutral )

-0.30
( neutral )

-0.65
( moderate negative )

0.64
( weak )

Adverum Biotechnologies Finanzas

Annual	2023
Ingresos:	$3.60M
Beneficio Bruto:	$-2.04M (-56.78 %)
EPS:	$-11.62

FY	2023
Ingresos:	$3.60M
Beneficio Bruto:	$-2.04M (-56.78 %)
EPS:	$-11.62

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-6.53M (0.00 %)
EPS:	$-15.57

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.709

Financial Reports:

No articles found.

Adverum Biotechnologies

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Actualizaciones en tiempo real para Adverum Biotechnologies [ADVM]

Upcoming Earnings Alert